Guardant Health, Inc. - Common Stock (GH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
GH on Nasdaq
Shares outstanding
123,850,680
Price per share
$102.14
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
122,491,737
Total reported value
$7,652,954,403
% of total 13F portfolios
0.01%
Share change
-1,731,398
Value change
-$62,643,518
Number of holders
386
Price from insider filings
$102.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $460,074,314 9,288,801 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $258,624,114 5,221,565 Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $240,233,923 4,850,271 Wellington Management Group LLP 31 Dec 2024

As of 30 Sep 2025, 386 institutional investors reported holding 122,491,737 shares of Guardant Health, Inc. - Common Stock (GH). This represents 99% of the company’s total 123,850,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Guardant Health, Inc. - Common Stock (GH) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.6% 11,908,829 -2.1% 0.01% $744,063,636
BlackRock, Inc. 9.2% 11,429,315 +4.1% 0.01% $714,103,610
BAILLIE GIFFORD & CO 4.1% 5,127,692 +6.6% 0.24% $320,378,195
Invesco Ltd. 4% 4,929,543 +39% 0.05% $307,997,846
Capital International Investors 3.8% 4,689,241 -5.8% 0.05% $292,983,778
PRICE T ROWE ASSOCIATES INC /MD/ 3.4% 4,221,637 +139% 0.03% $263,769,000
Deep Track Capital, LP 3.4% 4,154,086 -2.3% 7.2% $259,547,293
EVENTIDE ASSET MANAGEMENT, LLC 2.7% 3,321,338 -4% 3.4% $207,506,637
WELLINGTON MANAGEMENT GROUP LLP 2.6% 3,249,085 +69% 0.04% $203,002,832
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,936,656 +0.55% 0.01% $183,509,854
FRANKLIN RESOURCES INC 2.4% 2,926,315 +26% 0.05% $182,836,178
STATE STREET CORP 2.3% 2,787,777 -1.8% 0.01% $174,180,307
FULLER & THALER ASSET MANAGEMENT, INC. 1.9% 2,369,568 +7.8% 0.5% $148,050,583
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.8% 2,261,869 -23% 0.03% $141,321,576
Driehaus Capital Management LLC 1.7% 2,152,315 -13% 0.96% $134,476,641
CADIAN CAPITAL MANAGEMENT, LP 1.7% 2,141,191 -33% 8% $133,781,614
TWO SIGMA ADVISERS, LP 1.7% 2,112,800 -11% 0.26% $132,007,744
Alyeska Investment Group, L.P. 1.5% 1,831,318 0.35% $114,420,749
TWO SIGMA INVESTMENTS, LP 1.5% 1,803,331 -2.8% 0.17% $112,672,121
FEDERATED HERMES, INC. 1.4% 1,776,369 +21% 0.2% $110,987,536
LORD, ABBETT & CO. LLC 1.2% 1,523,635 +72% 0.28% $95,197,000
GOLDMAN SACHS GROUP INC 1.2% 1,506,210 +31% 0.01% $94,108,001
RTW INVESTMENTS, LP 1.2% 1,481,033 +73% 1.1% $92,534,942
JENNISON ASSOCIATES LLC 1.2% 1,471,294 +106% 0.05% $91,926,448
UBS Group AG 1.2% 1,457,051 +23% 0.02% $91,036,546

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 907,142 $92,430,472 +$1,201,573 $102.14 25
2025 Q3 122,491,737 $7,652,954,403 -$62,643,518 $62.48 386
2025 Q2 124,295,969 $6,467,826,507 +$330,760,770 $52.04 359
2025 Q1 118,497,703 $5,048,168,027 +$16,046,986 $42.60 336
2024 Q4 119,495,658 $3,649,677,643 -$152,886,448 $30.55 294
2024 Q3 124,539,664 $2,855,453,478 +$192,800,636 $22.94 264
2024 Q2 114,848,348 $3,316,872,682 +$179,592,491 $28.88 274
2024 Q1 111,383,571 $2,296,334,142 -$29,707,645 $20.63 252
2023 Q4 110,309,454 $2,983,894,470 +$45,961,733 $27.05 289
2023 Q3 108,297,993 $3,210,080,906 -$83,646,730 $29.64 289
2023 Q2 110,144,879 $3,943,258,288 +$694,610,966 $35.80 293
2023 Q1 92,579,337 $2,168,850,990 -$17,004,713 $23.44 271
2022 Q4 94,289,245 $2,564,763,814 -$199,503,944 $27.20 280
2022 Q3 94,962,606 $5,108,852,818 +$162,272,236 $53.83 310
2022 Q2 92,768,225 $3,745,003,930 -$39,996,274 $40.34 310
2022 Q1 92,443,619 $6,110,748,734 -$81,915,249 $66.24 335
2021 Q4 92,085,897 $9,209,883,362 -$251,467,115 $100.02 379
2021 Q3 94,130,065 $11,765,302,482 +$583,304,963 $125.01 365
2021 Q2 89,577,134 $11,124,047,648 -$275,498,694 $124.19 410
2021 Q1 91,351,911 $13,941,648,366 +$681,296,473 $152.65 410
2020 Q4 87,374,557 $11,260,127,731 +$219,249,861 $128.88 399
2020 Q3 85,443,260 $9,550,543,816 +$176,117,596 $111.78 341
2020 Q2 84,323,375 $6,840,933,865 +$491,051,528 $81.13 311
2020 Q1 78,329,707 $5,451,350,483 +$31,071,063 $69.60 281
2019 Q4 77,055,101 $6,021,065,515 +$259,064,552 $78.14 261
2019 Q3 73,811,798 $4,711,407,821 -$154,907,012 $63.83 230
2019 Q2 75,988,996 $6,559,989,770 +$1,412,721,312 $86.33 214
2019 Q1 60,292,447 $4,622,332,723 +$11,801,888 $76.70 144
2018 Q4 61,703,860 $2,318,551,779 +$2,050,102,770 $37.59 87